Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation. [electronic resource]
Producer: 20171220Description: 50-59 p. digitalISSN:- 1555-905X
- Adolescent
- Adult
- Aged
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Atypical Hemolytic Uremic Syndrome -- drug therapy
- Child
- Child, Preschool
- Complement Factor H -- genetics
- Complement System Proteins -- genetics
- Female
- Follow-Up Studies
- Humans
- Male
- Membrane Cofactor Protein -- genetics
- Middle Aged
- Recurrence
- Withholding Treatment
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.